Expertise in
4
conditions

Dr. Theresa Karplus

Rheumatology
700 Ne 87th Ave, 
Vancouver, WA 
Expertise in
4
conditions
700 Ne 87th Ave, 
Vancouver, WA 

Overview

Theresa Karplus is a Rheumatologist in Vancouver, Washington. Dr. Karplus is highly rated in 4 conditions, according to our data. Her top areas of expertise are Rheumatoid Arthritis (RA), Axial Spondyloarthritis (AxSpA), Ankylosing Spondylitis, and Rheumatoid Vasculitis.

Her clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Rheumatology

Licenses

Internal Medicine in WA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

700 Ne 87th Ave, Vancouver, WA 98664

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: March 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
James T. Rosenbaum
Expertise in
26
conditions
Dr. James T. Rosenbaum
Rheumatology | Ophthalmology
Expertise in
26
conditions
Dr. James T. Rosenbaum
Rheumatology | Ophthalmology

Legacy Good Samaritan Hospital And Medical Center

1040 Nw 22nd Ave, Suite 168, 
Portland, OR 
 (8.5 miles away)
503-413-7022
Languages Spoken:
English
See accepted insurances
Accepting New Patients

James Rosenbaum is a Rheumatologist and an Ophthalmologist in Portland, Oregon. Dr. Rosenbaum is highly rated in 26 conditions, according to our data. His top areas of expertise are Uveitis, Scleritis, Sarcoidosis, Vitrectomy, and Trabeculectomy. Dr. Rosenbaum is currently accepting new patients.

Expertise in
20
conditions
Dr. Peter P. Bonafede
Rheumatology
Expertise in
20
conditions
Dr. Peter P. Bonafede
Rheumatology
5050 Northeast Hoyt Street, Suite 155, 
Portland, OR 
 (6.1 miles away)
503-215-6819
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Peter Bonafede is a Rheumatologist in Portland, Oregon. Dr. Bonafede is highly rated in 20 conditions, according to our data. His top areas of expertise are Rheumatoid Lung Disease, Rheumatoid Pneumoconiosis, Ankylosing Spondylitis, and Axial Spondyloarthritis (AxSpA). Dr. Bonafede is currently accepting new patients.

Expertise in
17
conditions
Dr. Kevin P. Khaw
Rheumatology
Expertise in
17
conditions
Dr. Kevin P. Khaw
Rheumatology

Portland Adventist Medical Center

10101 Se Main St, Suite 2011, 
Portland, OR 
 (7.8 miles away)
503-261-6912
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kevin Khaw is a Rheumatologist in Portland, Oregon. Dr. Khaw is highly rated in 17 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia. Dr. Khaw is currently accepting new patients.

Frequently Asked Questions about Dr. Theresa Karplus

How do I make an appointment with Dr. Theresa Karplus?

You can book an appointment with Dr. Theresa Karplus by calling their office at 360-882-2778. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Theresa Karplus a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Theresa Karplus is classified as an Distinguished expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Theresa Karplus specialize in?

While Dr. Theresa Karplus is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Axial Spondyloarthritis (AxSpA), and Ankylosing Spondylitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Theresa Karplus accept my insurance?

Dr. Theresa Karplus accepts most major insurance plans, including Cambia Health Solutions and Cigna. We recommend calling the office directly at 360-882-2778 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Karplus's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile